UIM5:F:F-UBS (Lux) Fund Solutions - MSCI Japan UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 50.858

Change

-0.34 (-0.66)%

Market Cap

USD 115.53B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.18 (-0.65%)

USD 139.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.22 (-0.22%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.32 (-0.57%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.95 (-0.40%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.64%)

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.09 (-0.09%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.23%)

USD 40.74B
0ZC:F Zscaler Inc

+5.22 (+3.51%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B

ETFs Containing UIM5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.23% 57% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.23% 54% F 54% F
Trailing 12 Months  
Capital Gain 12.74% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.74% 39% F 47% F
Trailing 5 Years  
Capital Gain 25.38% 48% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.38% 48% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 5.91% N/A N/A 60% D-
Dividend Return 5.91% N/A N/A 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.71% N/A N/A 84% B
Risk Adjusted Return 50.49% N/A N/A 69% C-
Market Capitalization 115.53B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike